Evidence map›Paper›PMID 39835064›Full record

ArticleCureus2024

Antimicrobial Utilization, Adverse Drug Reactions, and Associated Cost of Care in a Tertiary Care Hospital in Eastern India.

Prasenjit Sutradhar, Mangala C Das, Sarada P Suna, Chaitali Pattanayak, Prem S Panda, Ipsita Debata

Abstract read
In one paragraph

Article in Cureus, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Prasenjit SutradharPharmacology, Kalinga Institute of Medical Sciences, Bhubaneswar, IND.
Mangala C DasPharmacology, Kalinga Institute of Medical Sciences, Bhubaneswar, IND.
Sarada P SunaMedicine, Kalinga Institute of Medical Sciences, Bhubaneswar, IND.
Chaitali PattanayakPharmacology and Therapeutics, Kalinga Institute of Medical Sciences, Bhubaneswar, IND.
Prem S PandaCommunity Medicine, Kalinga Institute of Medical Sciences, Bhubaneswar, IND.
Ipsita DebataCommunity Medicine, Kalinga Institute of Medical Sciences, Bhubaneswar, IND.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background Antimicrobials considerably reduce infectious conditions, but their overuse and misuse contribute to various adverse drug reactions (ADRs) and antimicrobial resistance. In 2019, India adopted a national program to reduce antibiotic resistance for 2019-2021. Assessing antibiotic consumption among the out-patient and in-patient departments is paramount because it is the foundation for implementing and assessing antibiotic stewardship initiatives. This study aims to evaluate the usage pattern, ADR of antimicrobials and cost of treatment due to the use of antibiotics in patients admitted to selected departments of a tertiary care hospital in Eastern India. Material and methods An observational cross-sectional study was conducted on adult in-patients getting admitted to selected departments and ICUs of Kalinga Institute of Medical Sciences (KIMS), Bhubaneswar. Data were collected using a convenience sampling method from 417 patients during July 2022 to January 2024. Study tools included the Case Record Form, WHO prescribing Indicators, and WHO Causality Assessment scale. Descriptive statistics were presented using frequencies and percentages. The chi-square test was done to analyze the associations among categorical variables. Results Middle-aged individuals had a higher likelihood of hospital admission and antibiotic administration. The gender distribution was almost equal in the study population. It was found that ceftriaxone was the most common antimicrobial used in Medicine 56 (18.5%) and Surgery 49 (18.2%) departments. In Orthopaedics and Obstetrics and Gynaecology (O&G) departments, the most common antimicrobials used were cefuroxime 37 (20.3%) and cefixime 32 (22.2%), respectively. Piperacillin-tazobactam 59 (16.3%) was the most frequently utilized antimicrobial in the ICU. The majority of the antibiotics 800 (65%) were prescribed from the Watch group of the WHO AWaRe Index. The cost of antimicrobial treatment was highest in the ICU and the least in the O&G department. None of the participants had any serious adverse effects related to antimicrobials. Conclusion The most common group of antimicrobials used in this study were beta-lactams. Ceftriaxone, cefuroxime, and piperacillin-tazobactam were the most common drugs prescribed. It was found that this study does not correspond with the optimal values of WHO core drug use prescribing indicators. None of the participants had any serious adverse effects related to antimicrobials.

Indexed as

adverse drug reactionantimicrobial resistanceantimicrobial usecost of treatmentwho aware index

Identifiers

PMID39835064
PMCPMC11743798

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.